Literature DB >> 16469008

Treatment targeted at vascular endothelial growth factor: a promising approach to managing metastatic kidney cancer.

Andres J Schrader1, Zoltan Varga, Susanne Pfoertner, Ulrike Goelden, Jan Buer, Rainer Hofmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16469008     DOI： 10.1111/j.1464-410X.2006.05873.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  5 in total

1.  Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.

Authors:  Shinichi Sakamoto; Steven Schwarze; Natasha Kyprianou
Journal:  Eur Urol       Date:  2011-01-12       Impact factor: 20.096

2.  [Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study].

Authors:  S Waalkes; F C Roos; H Eggers; S Schumacher; M Janssen; G Wegener; J W Thüroff; R Hofmann; M Schrader; M A Kuczyk; A J Schrader
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

Review 3.  Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.

Authors:  Shinichi Sakamoto; A Jacqueline Ryan; Natasha Kyprianou
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

4.  Incidence and long-term prognosis of papillary renal cell carcinoma.

Authors:  A J Schrader; S Rauer-Bruening; P J Olbert; A Hegele; J Rustemeier; N Timmesfeld; Z Varga; R Hofmann
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-21       Impact factor: 4.553

5.  The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma.

Authors:  Marcela García; Maria Belen Palma; Jerome Verine; Santiago Miriuka; Ana M Inda; Ana L Errecalde; François Desgrandchamps; Edgardo D Carosella; Diana Tronik-Le Roux
Journal:  BMC Cancer       Date:  2020-07-03       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.